Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | |
Div Cover | n/a | |
Op Mrgn | 1.4% | |
ROCE | 9.8% |
Latest | F'cast | |
---|---|---|
P/E | 378.8 | |
PEG | n/a | |
Pr/Revenue | 2.8 | |
Pr/Book | 3.4 |
Latest | F'cast | |
---|---|---|
Revenue | 14.8% | |
PBT | -62.0% | |
EPS | -94.0% | |
DPS | n/a |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 2,666.70 | (232.22) | (136.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 2,986.27 | 570.44 | 430.00¢ | 17.1 | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 3,394.64 | 529.12 | 153.00¢ | 52.5 | n/a | -64% | n/a | 0.0% |
31-Dec-23 | 3,695.65 | 834.22 | 267.00¢ | 23.5 | 0.3 | +74% | n/a | 0.0% |
31-Dec-24 | 4,241.22 | 316.63 | 16.00¢ | 431.7 | n/a | -94% | n/a | 0.0% |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 4,668.84 | 1,336.70 | 583.30¢ | 10.7 | 0.0 | +3,546% | n/a | 0.0% |
31-Dec-26 | 5,097.73 | 1,633.81 | 684.54¢ | 9.2 | 0.5 | +17% | n/a | 0.0% |
31-Dec-27 | 5,594.08 | 2,013.86 | 854.67¢ | 7.3 | 0.3 | +25% | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
FDA grants EUA for Eli Lilly treatment in conjun... | 20-Nov-2020 | ShareCast |
Currency | US Dollars |
Share Price | $ 62.32 |
Change Today | $ -0.35 |
% Change | -0.55 % |
52 Week High | $83.38 |
52 Week Low | $51.68 |
Volume | 709,006 |
Shares Issued | 193.43m |
Market Cap | $12,054m |
RiskGrade | 196 |
Strong Buy | 7 |
Buy | 2 |
Neutral | 13 |
Sell | 2 |
Strong Sell | 0 |
Total | 24 |
Time | Volume / Share Price |
11:40 | 100 @ $62.32 |
11:40 | 100 @ $62.32 |
11:40 | 100 @ $62.32 |
11:39 | 100 @ $62.32 |
11:39 | 265 @ $62.32 |
You are here: research